Failure Rate of Anti-Tumor Necrosis Factor α Biologics in Very Early Onset Inflammatory Bowel Disease
- PMID: 38207012
- DOI: 10.1093/ibd/izad313
Failure Rate of Anti-Tumor Necrosis Factor α Biologics in Very Early Onset Inflammatory Bowel Disease
Comment in
-
Response to Letter to the Editor: "Failure Rate of Antitumor Necrosis Factor Alpha Biologics in Very Early Onset Inflammatory Bowel Disease".Inflamm Bowel Dis. 2024 Mar 1;30(3):513-514. doi: 10.1093/ibd/izad317. Inflamm Bowel Dis. 2024. PMID: 38206353 Free PMC article. No abstract available.
Comment on
-
Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.Inflamm Bowel Dis. 2024 Sep 3;30(9):1443-1453. doi: 10.1093/ibd/izad196. Inflamm Bowel Dis. 2024. PMID: 37847820 Free PMC article.
-
Response to Letter to the Editor: "Failure Rate of Antitumor Necrosis Factor Alpha Biologics in Very Early Onset Inflammatory Bowel Disease".Inflamm Bowel Dis. 2024 Mar 1;30(3):513-514. doi: 10.1093/ibd/izad317. Inflamm Bowel Dis. 2024. PMID: 38206353 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
